Continuing Education Courses
Continuing Education for MLS & MLT
Continuing Education for Phlebotomists
Continuing Education for Histologists
HR Courses
Intro to the Medical Lab
Video Continuing Education Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
RBC Morphology Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
Urinalysis Case Simulator
Body Fluid Case Simulator
Bacteriology Case Simulator
Blood Culture Gram Stain Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
Which statement is true regarding the use of aspirin to prevent PE?
This version of the course is no longer available.
Need multiple seats for your university or lab?
Get a quote
The page below is a sample from the LabCE course
Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers (retired 4/6/2020)
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers (retired 4/6/2020) (online CE course)
Which statement is true regarding the use of aspirin to prevent PE?
More than one answer
is correct. Please select all correct answers
Guidelines recommend the use of low-dose aspirin after 12 weeks of pregnancy in all pregnant women.
Studies have shown that aspirin treatment of women at high risk for PE reduces the risk of developing the disease by as much as 50%.
When using aspirin to prevent PE, the recommended dose is 81mg/day.
When using low-dose aspirin treatment, one cannot rule out a rare harm associated with its use.
X
×